Systems Biology and Longevity: An Emerging Approach to Identify Innovative Anti- Aging Targets and Strategies
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Human aging and longevity are complex and multi-factorial traits that result from a combination of environmental, genetic, epigenetic and stochastic factors, each contributing to the overall phenotype. The multi-factorial process of aging acts at different levels of complexity, from molecule to cell, from organ to organ systems and finally to organism, giving rise to the dynamic "aging mosaic". At present, an increasing amount of experimental data on genetics, genomics, proteomics and other -omics are available thanks to new high-throughput technologies but a comprehensive model for the study of human aging and longevity is still lacking. Systems biology represents a strategy to integrate and quantify the existing knowledge from different sources into predictive models, to be later tested and then implemented with new experimental data for validation and refinement in a recursive process. The ultimate goal is to compact the new acquired knowledge into a single picture, ideally able to characterize the phenotype at systemic/organism level. In this review we will briefly discuss the aging phenotype in a systems biology perspective, showing four specific examples at different levels of complexity, from a systemic process (inflammation) to a cascade-process pathways (coagulation) and from cellular organelle (proteasome) to single gene-network (PON-1), which could also represent targets for anti-aging strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701361104 · Cited by 3,242
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087 · cited 1×
“In the aging field, this consideration is particularly important for “inflammaging”, [46,56,57], which appears to be important in the pathogenesis of cardiovascular diseases (CVD), type 2 diabetes (T2D), metabolic syndrome (MS), neurodegeneration, sarcopenia and cancer, among others.”
BackgroundSelf-citationPleiotropy, natural selection, and the evolution of senescence
Williams, G. C. (1957) · Evolution · doi:10.2307/2406060 · Cited by 1,912
Protein degradation by the ubiquitin-proteasome pathway in normal and disease states
Lecker, S. H., Goldberg, A. L., & Mitch, W. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010083 · Cited by 1,234
Epigenetics and aging: the targets and the marks
Fraga, M. F., & Esteller, M. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.05.008 · Cited by 690 · cited 1×
“To this regard, "aging epigenetics" became an emerging discipline [34,35].”
BackgroundAGEMAP: A Gene Expression Database for Aging in Mice
Zahn, J. M., Poosala, S., Owen, A. B., Ingram, D. K., Lustig, A., Carter, A., Weeraratna, A. T., Taub, D. D., Gorospe, M., Mazan-Mamczarz, K., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030201 · Cited by 431 · cited 4×
“In mice it has been observed that different tissues age in a coordinated fashion [9], while in humans this is still to be ascertained.”
BackgroundInfluentialInflammaging as a Major Characteristic of Old People: Can It Be Prevented or Cured?
Franceschi, C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00358.x · Cited by 342
Self-citationCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
Delayed and Accelerated Aging Share Common Longevity Assurance Mechanisms
Schumacher, B., van der Pluijm, I., Moorhouse, M. J., Kosteas, T., Robinson, A. R., Suh, Y., Breit, T. M., van Steeg, H., Niedernhofer, L. J., van IJcken, W., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000161 · Cited by 212 · cited 1×
“A more comprehensive approach to understand the complexity of this mosaic would be the simultaneous study of several organs at once; at present, this strategy has been applied only to animal models, as reported in mice by Schumacher B and co-workers [26].”
MethodLicastro, F., Grimaldi, L. M. E., Bonafè, M., Martina, C., Olivieri, F., Cavallone, L., Giovanietti, S., Masliah, E., & Franceschi, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00013-7 · Cited by 182 · cited 1×
“An age-related increase in the production of inflammatory compounds occurs in the immune system [58,59], brain [60], adipose tissue [61] and muscle [62], but the possible contribution to inflammaging of other organs or districts, such as gut microbiota and liver, is largely unexplored.”
BackgroundSelf-citationVescovini, R., Biasini, C., Fagnoni, F. F., Telera, A. R., Zanlari, L., Pedrazzoni, M., Bucci, L., Monti, D., Medici, M. C., Chezzi, C., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4283 · Cited by 173 · cited 1×
“An age-related increase in the production of inflammatory compounds occurs in the immune system [58,59], brain [60], adipose tissue [61] and muscle [62], but the possible contribution to inflammaging of other organs or districts, such as gut microbiota and liver, is largely unexplored.”
BackgroundSelf-citationCedersund, G., & Roll, J. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06845.x · Cited by 127 · cited 1×
“In addition, it also offers tools to develop predictive mathematical models and networks [40], able to evaluate and compare potential explanations for biological data [41].”
BackgroundAging in Mouse and Human Systems: A Comparative Study
DEMETRIUS, L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.010 · Cited by 100 · cited 1×
“However it should be taken into account that extrapolation of results from experimental animals (mice) to humans is not always straightforward, mainly due to the quantitative differences in maintenance and reproduction [27].”
BackgroundThe unusual genetics of human longevity
De Benedictis, G., & Franceschi, C. (2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.10.pe20 · Cited by 83
Self-citationThe extreme longevity: The state of the art in Italy
Franceschi, C., Motta, L., Motta, M., Malaguarnera, M., Capri, M., Vasto, S., Candore, G., & Caruso, C. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2007.06.006 · Cited by 83
Self-citationDoyle, F. J., & Stelling, J. (2006) · Journal of The Royal Society Interface · doi:10.1098/rsif.2006.0143 · Cited by 60
Proctor, C. J., Tsirigotis, M., & Gray, D. A. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-17 · Cited by 34 · cited 1×
“A first attempt to describe, in a systems biology framework, the ubiquitin-proteasome system in normal homeostasis as well as during aging, has been reported by Proctor and co-worker [76], while a more recent model of on-going conflicts between the aggregation of -synuclein ( SN) and the maintenance of a functional pr…”
Background
Cited by
A synopsis on aging—Theories, mechanisms and future prospects
da Costa, J. P., Vitorino, R., Silva, G. M., Vogel, C., Duarte, A. C., & Rocha-Santos, T. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.005 · Cited by 456
Cevenini, E., Monti, D., & Franceschi, C. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32835ada13 · Cited by 317
“To analyze comprehensively these data, a systems biology approach has been proposed as the most powerful tool to characterize the systemic nature of inflamm-ageing, for example by developing predictive models of inflamm-ageing, needed to set up strategies for the modulation of inflammation [7].”
BackgroundMethodSelf-citationOstan, R., Monti, D., Gueresi, P., Bussolotto, M., Franceschi, C., & Baggio, G. (2016) · Clinical Science · doi:10.1042/cs20160004 · Cited by 260
Self-citationOlivieri, F., Spazzafumo, L., Santini, G., Lazzarini, R., Albertini, M. C., Rippo, M. R., Galeazzi, R., Abbatecola, A. M., Marcheselli, F., Monti, D., et al. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.09.004 · Cited by 248
“Human aging is a highly complex process characterized by the remodeling of many molecular pathways involved in cellular and tissue homeostasis (Spazzafumo et al., 2011; Cevenini et al., 2010; Bonafè et al., 2003).”
BackgroundSelf-citationInflammaging and human longevity in the omics era
Monti, D., Ostan, R., Borelli, V., Castellani, G., & Franceschi, C. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.008 · Cited by 167
Self-citation
Metadata
- Authors
- Cevenini, E., Bellavista, E., Tieri, P., Castellani, G., Lescai, F., Francesconi, M., Mishto, M., Santoro, A., Valensin, S., Salvioli, S., Capri, M., Zaikin, A., Monti, D., de Magalhaes, J., & Franceschi, C.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-03-01
- Volume
- 16
- Issue
- 7
- Pages
- 802-813
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2107047038
- Cited by
- 71
- References
- 19
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.